BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 333568)

  • 1. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
    Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response.
    Mulgirigama LD; Pare CM; Turner P; Wadsworth J; Witts DJ
    Postgrad Med J; 1977; 53 Suppl 4():155-9. PubMed ID: 341104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and biochemical contributions on the action of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 13(3):164-72. PubMed ID: 93762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pharmacotherapy of masked depression].
    Kielholz VP
    Wien Med Wochenschr; 1975 May; 125(21):327-9. PubMed ID: 3030
    [No Abstract]   [Full Text] [Related]  

  • 11. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
    Ridges AP; Bishop FM; Lawton K; Goldberg IJ
    Postgrad Med J; 1980; 56 Suppl 1():37-41. PubMed ID: 6156444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--II. Report on a placebo-controlled clinical trial.
    Pecknold JC; Amin MM; Ban TA; Orbach L
    Psychopharmacol Bull; 1976 Jan; 12(1):24-5. PubMed ID: 1108078
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--I. Report on an uncontrolled clinical trial.
    Campbell P; Ananth JV; Gomez L
    Psychopharmacol Bull; 1976 Jan; 12(1):23-4. PubMed ID: 1108077
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
    Pecknold JC; Gratton L; Ban TA; Klingner A
    Psychopharmacol Bull; 1976 Jan; 12(1):26-7. PubMed ID: 1108079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of maprotiline in the treatment of depressions in predominantly geriatric patients. Preliminary report].
    Hochenegg L
    Wien Med Wochenschr; 1976 Dec; 126(49-50):702-5. PubMed ID: 795169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.